Evaluation of ivabradine in left ventricular dyssynchrony and reverse remodeling in patients with chronic heart failure

---

Copy For Citation

Soylu K., ÇERİK İ. B., Aksan G., NAR G., Meriç M.

JOURNAL OF ARRHYTHMIA, vol.36, no.4, pp.762-767, 2020 (ESCI)

• Publication Type: Article / Article
• Volume: 36 Issue: 4
• Publication Date: 2020
• Doi Number: 10.1002/joa3.12398
• Journal Name: JOURNAL OF ARRHYTHMIA
• Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, Directory of Open Access Journals
• Page Numbers: pp.762-767
• Keywords: dyssynchrony, heart failure, ivabradine, CARDIAC-RESYNCHRONIZATION THERAPY, IDIOPATHIC DILATED CARDIOMYOPATHY, RATE REDUCTION, QRS DURATION, CARVEDILOL, DEFIBRILLATOR, ABNORMALITIES, MORTALITY, TRIAL
• Ondokuz Mayıs University Affiliated: Yes

Abstract

Objectives: Ivabradine is a pharmacological agent used in patients with heart failure and sinus rhythm. Its only known pharmacological effect is to slow the heart rate. In this study, we investigated the impact of ivabradine on dyssynchrony parameters in heart failure patients.